Dementia Drug Gains Approval
105566
A skin patch to treat the dementia suffered by Alzheimerâs patients has gained federal approval, a drug company said.
658689
A new study shows a possible link between cholesterol drugs and the prevention of Alzheimerâs disease.
95647
A new drug to treat Alzheimer&#39;s disease has been approved by Health Canada. It doesn&#39;t cure the disease, but it can slow down its effects, giving patients more mental clarity.
733890
NEW YORK, NOVEMBER 25: The Federal Government has just approved a new medicine for multiple sclerosis that doctors say represents a new treatment approach that will significantly reduce the frequency of disabling episodes.
767499
Tablets containing a combination of the blood pressure medication aliskiren and water pill hydrochlorothiazide have been approved by the Food and Drug Administration
147168
The approval of a new drug is a long-term opportunity.
349668
The first drug shown to significantly improve the vision of patients threatened by a major cause of blindness in the elderly won federal approval Friday.
79075
Eli Lilly pushed Zyprexa, a drug for schizophrenia and bipolar disorder, as a treatment for older patients with dementia, according to marketing materials.
321841
The Food and Drug Administration yesterday approved a drug for multiple sclerosis that has shown early evidence of being more effective than existing drugs.
472642
Researchers have found that drugs being developed for Alzheimer&#39;s disease can also provide a better treatment for the cancer, T-cell acute lymphoblastic leukemia or T-ALL.
204632
Regulators are reviewing the safety of the Alzheimer's disease drug Reminyl after data from two clinical trials indicated that people taking the drug had a much higher death rate than those taking a placebo.
258793
The US government approved a drug Tuesday to treat multiple sclerosis, an incurable disease of the central nervous system that affects 350,000 Americans.
333366
The Food and Drug Administration approved a drug for multiple sclerosis that works by a new mode of action and has shown early evidence of being more effective than existing drugs.
518382
A new drug that fights a form of age-related macular degeneration (AMD), a leading cause of blindness in the elderly, won applause if not approval from a panel of advisors to the US Food and Drug Administration.
362552
Pharmaceuticals take British advisory agency to court to approve Alzheimer's treatment.
68266
Gilead gets marketing approval for one of its drug candidates.
619596
Bristol-Myers Squibb and Otsuka Pharmaceutical have announced that the US Food and Drug Administration (FDA) has approved Abilify (aripiprazole) for the treatment of acute bipolar mania, including manic and mixed episodes associated with bipolar disorder.